Welcome to today's Medical News Today News Alert containing today's medical news headlines for your chosen categories. You will only receive these alerts when new news is available for your chosen categories.
To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .
----------------------------------------------
** BREAST CANCER News **
Breast Cancer Screening Could Be Revolutionized By New Technology
http://www.medicalnewstoday.com/articles/129100.php
The world's first radar breast imaging system developed at Bristol University that could revolutionise the way women are scanned for breast cancer, is being trialled at North Bristol NHS Trust (NBT).
Breast Cancer Screening Could Be Revolutionized By New Technology
http://www.medicalnewstoday.com/articles/129099.php
The world's first radar breast imaging system developed at Bristol University that could revolutionise the way women are scanned for breast cancer, is being trialled at North Bristol NHS Trust (NBT).
The Genetics Of Breast Cancer Studied Using New Technique
http://www.medicalnewstoday.com/articles/129094.php
A new technique to study genetic changes that can lead to breast cancer could be one step closer.The University of Nottingham has received £15,000 from the charity Breast Cancer Campaign to fill in one of the research gaps identified by the country's top breast cancer experts in a recent study carried out by the charity.
No Association Between Calcium Plus Vitamin D Supplementation And Reduced Breast Cancer Risk
http://www.medicalnewstoday.com/articles/129089.php
Taking calcium and vitamin D supplements does not reduce breast cancer incidence in postmenopausal women, according to data from a randomized, doubled-blind, placebo-controlled trial published online November 11 in the <i>Journal of the National Cancer Institute.
Women Risk Their Lives By Failing To Take Breast Cancer Drugs
http://www.medicalnewstoday.com/articles/129043.php
Breast cancer patients are risking their lives by failing to take the <a href="http://www.cancerhelp.org.uk/help/default.asp?page=18399" target="_blank" rel="nofollow">tamoxifen</a> they are prescribed, according to a new study published in the <a href="http://www.
----------------------------------------------
** CANCER / ONCOLOGY News **
Cancer Care Of Western New York Becomes First Center In Western New York To Treat Cancer With RapidArc Radiotherapy Technology
http://www.medicalnewstoday.com/articles/129140.php
During his annual physical check-up in March, David Kelver's doctor noticed he'd never had his tonsils out, and remarked that the right one looked a bit swollen. The doctor concluded, however, that the problem was minor and would clear up on its own, and sent him home.
Allergies May Prevent Some Cancers
http://www.medicalnewstoday.com/articles/129124.php
There may be a silver -- and healthy -- lining to the miserable cloud of allergy symptoms: Sneezing, coughing, tearing and itching just may help prevent cancer -- particularly colon, skin, bladder, mouth, throat, uterus and cervix, lung and gastrointestinal tract cancer, according to a new Cornell study.
Investigation Into Benign Moles And Malignant Melanoma
http://www.medicalnewstoday.com/articles/129098.php
Research into a cancer that is on the rise in the UK is to be presented at the University of Leicester.It will discuss new studies at Leicester into the differences between benign and cancerous moles.
Grant To Continue Neuropathy Research Awarded To McGill Professor
http://www.medicalnewstoday.com/articles/129072.php
Dr. Gary J. Bennett, a professor at McGill University's Department of Anesthesia, has been awarded a scientific research grant by The Neuropathy Association, a U.S. patient-based non-profit organization headquartered in New York City.
Seventh Annual International Conference On Frontiers In Cancer Prevention Research
http://www.medicalnewstoday.com/articles/129056.php
<b>WHEN:</b> November 16 - 19, 2008<b>WHERE:</b>Gaylord National Resort &Convention CenterWashington, DC PROGRAM COMMITTEE CHAIRPERSON: Steven M. Dubinett, David Geffen School of Medicine at UCLA, Los Angeles, CAThrough this annual conference and the AACR family of journals, including the newest journal, <i>Cancer Prevention Research</i>, AACR will continue to serve as a central point for disseminating information and cultivating the interactions that are so vital to advancing the cancer prevention field.
Women Risk Their Lives By Failing To Take Breast Cancer Drugs
http://www.medicalnewstoday.com/articles/129043.php
Breast cancer patients are risking their lives by failing to take the <a href="http://www.cancerhelp.org.uk/help/default.asp?page=18399" target="_blank" rel="nofollow">tamoxifen</a> they are prescribed, according to a new study published in the <a href="http://www.
AACR To Host Seventh Annual International Conference On Frontiers In Cancer Prevention Research
http://www.medicalnewstoday.com/articles/129015.php
The American Association for Cancer Research's Seventh Annual International Conference on <a href="http://www.aacr.org/home/scientists/meetings--workshops/frontiers-in-cancer-prevention-research.
Cancer Risk From Cardiac CT Overstated: Medical University Of South Carolina Researchers
http://www.medicalnewstoday.com/articles/128999.php
Radiology and cardiovascular researchers from the Medical University of South Carolina in Charleston, S.C., have presented new data that shows the risk of cancer from exposure to radiation during computed tomography for cardiovascular disease has been overstated and that new estimates are several times lower than previously published conclusions.
Cancer Drugs May Build And Not Tear Down Blood Vessels
http://www.medicalnewstoday.com/articles/128997.php
Scientists have thought that one way to foil a tumor from generating blood vessels to feed its growth - a process called angiogenesis - was by creating drugs aimed at stopping a key vessel growth-promoting protein.
----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **
LSUHSC Public Health Contributes To Estimate Of HPV-Related Cancers
http://www.medicalnewstoday.com/articles/129108.php
Professor Vivien Chen, PhD,. Associate Professor Xiao Cheng Wu, MD, PhD and Assistant Professor Edward Peters, DMD, SM, ScD, at LSU Health Sciences Center New Orleans School of Public Health contributed five papers to the largest most comprehensive assessment of the burden of human papillomavirus (HPV)-associated cancers in the United States to date.
'Women Against Cervical Cancer' - A New International Network Committed To Empowering Women Through Education
http://www.medicalnewstoday.com/articles/129016.php
New survey results announced today, reveal a significant lack of information and education about the prevention, treatment and consequences of cervical cancer is leaving women unnecessarily worried and anxious.
----------------------------------------------
** COLORECTAL CANCER News **
Messages Of Hope Work Better In Motivating Black Patients To Seek Early Screening For Cancer
http://www.medicalnewstoday.com/articles/129126.php
News articles that stress African-American health disparities, like higher cancer mortality rates than other groups, may discourage black patients from being screened for cancer, according to a Saint Louis University study.
----------------------------------------------
** LUNG CANCER News **
News From The Journal Of The National Cancer Institute, Nov. 11
http://www.medicalnewstoday.com/articles/129093.php
<b>Overexpression of OLC1 Gene Associated with Smoking-Related Lung Cancer</b>The Overexpressed in Lung Cancer 1 (OLC1) gene is expressed at high levels in the majority of lung cancers, more often in samples from smokers than nonsmokers, and its expression is increased in cells treated with cigarette smoke.
----------------------------------------------
** LYMPHOMA / LEUKEMIA News **
Cell Therapeutics' Pixantrone Phase III (EXTEND) Pivotal Trial Successful In Achieving Primary Endpoint
http://www.medicalnewstoday.com/articles/128985.php
Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) announced that it achieved the primary efficacy endpoint of its phase III EXTEND (PIX301) trial of pixantrone (BBR2778) for patients with advanced, relapsed aggressive non-Hodgkin's lymphoma (NHL) based on a preliminary intent to treat efficacy analysis.
----------------------------------------------
** PROSTATE / PROSTATE CANCER News **
No news for this category today.
-------------------------------------------------------------
You are receiving this news alert e-mail because you subscribed via an online form on our web site. If you wish to unsubscribe, please visit
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .
No comments:
Post a Comment